AK
Anup Kumar Saha
About Anup Kumar Saha
Data last updated:
Anup Kumar Saha has 18 years in corporate governance. Holds Director role. Currently with 2 companies, including Saha Biological Pvt Ltd and Lyf Pharma Works Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Saha Biological Pvt Ltd at ₹2.92 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Saha Biological Pvt Ltd U24231WB1980PTC032587 | Director | 26 Mar 2008 | 1980 | ₹2.92 Cr (FY 2024) | Active |
| Lyf Pharma Works Private Limited U21001WR2026PTC295577 | Director | 27 Jul 2026 | 2026 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anup Kumar Saha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anup Kumar Saha
Anup Kumar Saha has 18 years in corporate governance. Holds Director role. Currently with 2 companies, including Saha Biological Pvt Ltd and Lyf Pharma Works Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Saha Biological Pvt Ltd at ₹2.92 Cr (FY 2024).
Anup Kumar Saha is associated with 2 companies as Director, including Saha Biological Pvt Ltd (₹2.92 Cr), Lyf Pharma Works Private Limited.
Anup Kumar Saha has expertise in General Business.
Anup Kumar Saha has 18 years in corporate governance.
By reported revenue, the largest current company of Anup Kumar Saha is Saha Biological Pvt Ltd, with revenue of ₹2.92 Cr (FY 2024).
Anup Kumar Saha currently holds positions at 2 companies: Saha Biological Pvt Ltd (₹2.92 Cr), Lyf Pharma Works Private Limited.